Albright, Andrew
Merck & Co., Inc., Rahway, NJ, USA (United States)
2 papers on CoChat
Most cited papers
- Verified
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
Ayers, M., Lunceford, J., Nebozhyn, M., Murphy, E., Loboda, A., Kaufman, D. R., Albright, A., Cheng, J. D., Kang, S. P., Shankaran, V., et al. (2017) · Journal of Clinical Investigation
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 3,788
- Verified
Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapy
Cristescu, R., Mogg, R., Ayers, M., Albright, A., Murphy, E., Yearley, J., Sher, X., Liu, X. Q., Lu, H., Nebozhyn, M., et al. (2018) · Science
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 2,301
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free